Clozaril Tablet
Product Images NDC 69809-0127

6 FDA label images from Hls Therapeutics (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clozaril (NDC 69809-0127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hls Therapeutics (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200 mg Clozaril Bottle Label

200 mg Clozaril Bottle Label
Label for Clozaril (clozapine) 200 mg oral tablets, containing 100 tablets per container. The label includes dosage and storage instructions, the National Drug Code (NDC) 69809-0135-05, and identifies HLS Therapeutics (USA), Inc. as the labeler. The product is marked Rx only and noted as made in Spain.*
FDA Label Image

50 mg Clozaril Bottle Label

50 mg Clozaril Bottle Label
Label for Clozaril 50 mg oral tablets by HLS Therapeutics (USA), Inc. The label indicates 100 tablets per container, with the active ingredient clozapine listed. It includes storage instructions, caution about ANC monitoring, and states the product is made in Spain. The label shows the NDC 69809-0130-05 and barcode.*
FDA Label Image

Structural Formula (Clozaril Figure 01)

Structural Formula (Clozaril Figure 01)
Chemical structure of clozapine, showing its molecular formula C18H19ClN4 and molecular weight of 326.83. The diagram depicts the chemical bonds and ring structures characteristic of clozapine.*
FDA Label Image

Figure 1 (Clozaril Figure 1)

Figure 1 (Clozaril Figure 1)
A line graph showing cumulative probability over time in months for Clozapine and Olanzapine. The graph depicts two lines: one solid line representing Clozapine and one dashed line representing Olanzapine, each increasing over a 24-month period, with final cumulative probabilities of 24% for Clozapine and 32% for Olanzapine.*
FDA Label Image

Principal Display Panel 100 mg (spain) (Clozaril 100mg 100 Tabs Spain)

Principal Display Panel 100 mg (spain) (Clozaril 100mg 100 Tabs Spain)
Label for Clozaril 100 mg tablets, an oral tablet formulation of clozapine, manufactured by HLS Therapeutics (USA), Inc. The label indicates a package of 100 tablets with prescription use only. It includes storage instructions, manufacturing information from Spain, and a warning about dispensing based on ANC results.*
FDA Label Image

Principal Display Panel 25 mg (spain) (Clozaril 25mg 100 Tabs Spain)

Principal Display Panel 25 mg (spain) (Clozaril 25mg 100 Tabs Spain)
Clozaril 25 mg oral tablets packaging label showing 100 tablets count. The label includes the proprietary name Clozaril, generic name clozapine, strength 25 mg, and manufacturer HLS Therapeutics (USA) Inc. It also contains storage instructions, dosage caution, and the NDC 69809-0126-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.